Polynoxylin
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Routes of administration | Topical |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | (C4H8N2O3)n |
| (verify) | |
|
WikiDoc Resources for Polynoxylin |
|
Articles |
|---|
|
Most recent articles on Polynoxylin Most cited articles on Polynoxylin |
|
Media |
|
Powerpoint slides on Polynoxylin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Polynoxylin at Clinical Trials.gov Clinical Trials on Polynoxylin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Polynoxylin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Polynoxylin Discussion groups on Polynoxylin Patient Handouts on Polynoxylin Directions to Hospitals Treating Polynoxylin Risk calculators and risk factors for Polynoxylin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Polynoxylin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Polynoxylin (trade name Anaflex) is an antiseptic for local treatment of the skin and the mouth. It is a polymer of urea and formaldehyde. The latter is the active principle after being released from the polymer.
